Ilaprazole: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
'''Ilaprazole''' is a [[proton pump inhibitor]] (PPI) used in the treatment of gastrointestinal diseases such as [[peptic ulcer disease]] (PUD), [[gastroesophageal reflux disease]] (GERD), and [[Zollinger-Ellison syndrome]]. It works by irreversibly blocking the [[H+/K+ ATPase]] enzyme system of the gastric parietal cells, leading to a reduction in gastric acid secretion.
{{Short description|Overview of the proton pump inhibitor Ilaprazole}}
{{Drugbox
| verifiedfields = changed
| verifiedrevid = 477002123
| image = Ilaprazole.svg
| image_size = 200px
| image_alt = Chemical structure of Ilaprazole
}}
 
'''Ilaprazole''' is a [[proton pump inhibitor]] (PPI) used in the treatment of [[gastroesophageal reflux disease]] (GERD) and other conditions involving excessive [[stomach acid]] production. It is known for its long-lasting effect and is used in various countries for managing acid-related disorders.


==Mechanism of Action==
==Mechanism of Action==
Ilaprazole inhibits the stomach's acid pump, the [[H+/K+ ATPase]] enzyme. This action stops the final step in acid production, thereby reducing gastric acidity. This mechanism is beneficial for allowing peptic ulcers to heal and for relieving the symptoms of acid reflux disease.
Ilaprazole works by inhibiting the [[H+/K+ ATPase]] enzyme system, also known as the proton pump, in the [[parietal cells]] of the stomach lining. This inhibition prevents the final step of acid production, thereby reducing gastric acidity.


==Pharmacokinetics==
==Pharmacokinetics==
Ilaprazole is characterized by its long-lasting inhibition of gastric acid secretion due to its prolonged plasma half-life. After oral administration, it is absorbed from the gastrointestinal tract, reaching peak plasma concentrations in 1.5 to 2.5 hours. It undergoes hepatic metabolism and is excreted primarily in the urine.
Ilaprazole is absorbed in the [[small intestine]] and undergoes hepatic metabolism primarily via the [[cytochrome P450]] enzyme system. It has a longer half-life compared to other PPIs, which contributes to its prolonged action.


==Clinical Uses==
==Clinical Uses==
Ilaprazole is used for the treatment of various acid-related gastrointestinal disorders, including:
Ilaprazole is primarily used for:
* [[Peptic ulcer disease]] (PUD)
* [[Gastroesophageal reflux disease]] (GERD)
* [[Gastroesophageal reflux disease]] (GERD)
* [[Peptic ulcer disease]]
* [[Zollinger-Ellison syndrome]]
* [[Zollinger-Ellison syndrome]]
It may also be used in combination with antibiotics for the eradication of ''[[Helicobacter pylori]]'' infection in patients with peptic ulcer disease.


==Side Effects==
==Side Effects==
Common side effects of ilaprazole include headache, dizziness, diarrhea, nausea, vomiting, and abdominal pain. Long-term use of PPIs, including ilaprazole, has been associated with an increased risk of bone fractures, kidney disease, and vitamin B12 deficiency.
Common side effects of Ilaprazole include:
* [[Headache]]
* [[Nausea]]
* [[Diarrhea]]
* [[Abdominal pain]]


==Comparison with Other PPIs==
==Comparison with Other PPIs==
Ilaprazole has been compared to other proton pump inhibitors in terms of efficacy and safety. Studies suggest that ilaprazole may offer a longer duration of acid suppression compared to some other PPIs, which could be beneficial for patients requiring sustained acid suppression.
Ilaprazole is often compared with other PPIs such as [[omeprazole]], [[lansoprazole]], and [[pantoprazole]]. It is noted for its longer duration of action and potentially fewer drug interactions.


==Conclusion==
==Related pages==
Ilaprazole is a valuable addition to the class of proton pump inhibitors, offering effective treatment for acid-related gastrointestinal disorders. Its long-lasting effect and safety profile make it a suitable option for patients needing prolonged acid suppression.
* [[Proton pump inhibitor]]
* [[Gastroesophageal reflux disease]]
* [[Peptic ulcer disease]]


[[Category:Proton pump inhibitors]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Pharmacology]]
<gallery>
[[Category:Proton pump inhibitors]]
File:Ilaprazole.svg|Ilaprazole chemical structure
 
</gallery>
{{Pharmacology-stub}}
{{Gastroenterology-stub}}

Latest revision as of 01:29, 20 February 2025

Overview of the proton pump inhibitor Ilaprazole


Ilaprazole
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


Ilaprazole is a proton pump inhibitor (PPI) used in the treatment of gastroesophageal reflux disease (GERD) and other conditions involving excessive stomach acid production. It is known for its long-lasting effect and is used in various countries for managing acid-related disorders.

Mechanism of Action[edit]

Ilaprazole works by inhibiting the H+/K+ ATPase enzyme system, also known as the proton pump, in the parietal cells of the stomach lining. This inhibition prevents the final step of acid production, thereby reducing gastric acidity.

Pharmacokinetics[edit]

Ilaprazole is absorbed in the small intestine and undergoes hepatic metabolism primarily via the cytochrome P450 enzyme system. It has a longer half-life compared to other PPIs, which contributes to its prolonged action.

Clinical Uses[edit]

Ilaprazole is primarily used for:

Side Effects[edit]

Common side effects of Ilaprazole include:

Comparison with Other PPIs[edit]

Ilaprazole is often compared with other PPIs such as omeprazole, lansoprazole, and pantoprazole. It is noted for its longer duration of action and potentially fewer drug interactions.

Related pages[edit]